Searchable abstracts of presentations at key conferences in endocrinology

ea0029p859 | Endocrine tumours and neoplasia | ICEECE2012

1,25-Dihydroxyvitamin D inhibits cell proliferation by promoting cell-cycle arrest in the human adrenocortical cancer cell line nci-h295r

Pilon C. , Urbanet R. , Vettore S. , Sirianni R. , Pezzi V. , Fallo F.

Vitamin D receptor (VDR) and its ligand 1,25-Dihydroxyvitamin D3 (1,25OHD3) play, in general, an inhibitory role on the growth of normal and malignant cells. However, the mechanisms for this anti-proliferative action remain not completely understood. Recently, a 1,25OHD3-mediated effect on hormone production and steroidogenic genes has been reported in the human steroid-secreting adrenocortical cancer cell line NCI-H295R (Lundqvist J et al. 2010). The aim of this study ...